Samlyn Capital’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Samlyn Capital's TEVA Position: Q2 2016 in Review
Samlyn Capital sold out of Teva Pharmaceutical Industries (TEVA) in Q2 2016, closing a stake of 1,954,175 shares — an estimated $105M sold.
Samlyn Capital first reported a position in TEVA in Q2 2014 and held it in 8 quarters. The position peaked at $143M in Q3 2015. 813 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.
- Samlyn Capital reported no remaining Teva Pharmaceutical Industries position as of Q2 2016 after selling out during the quarter.
- Samlyn Capital sold 1,954,175 Teva Pharmaceutical Industries shares in Q2 2016, an estimated $105M.
- Samlyn Capital first reported a position in Teva Pharmaceutical Industries in Q2 2014 and held it in 8 quarters.
- Samlyn Capital's Teva Pharmaceutical Industries position peaked at $143M in Q3 2015.
- 813 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q2 2016.
Based on Samlyn Capital's 13F filing for Q2 2016, filed 15 Aug 2016.